Aroonsiri Howell, MD, MPH, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University, provided perspective to NBC News about the U.S. Food and Drug Administration’s (FDA) approval of aducanumab, or Aduhelm, for Alzheimer’s disease. MSN.com picked up the NBC News piece.
Weather Alert: Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH